5-Aminosalicylic Acid Prevents Disease Behavior Progression and Intestinal Resection in Colonic and Ileocolonic Crohn's Disease Patients: A Retrospective Study

BACKGROUND AND AIMS: The efficacy of 5-aminosalicylic acid (5-ASA) in the long-term outcome of Crohn's disease (CD) patients was uncertain. This study aimed to evaluate the efficacy of the 5-ASA in preventing disease behavior progression and intestinal resection in CD patients. METHODS: CD pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Jian, Wang, Xuan, Zhang, Yujie, Xue, Xianmin, Li, Yani, Liu, Zhenzhen, Han, Shuang, Chen, Min, Nie, Yan, Shi, Yongquan, Liang, Jie, Wu, Kaichun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371663/
https://www.ncbi.nlm.nih.gov/pubmed/34422708
http://dx.doi.org/10.1155/2021/1412663

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371663/
https://www.ncbi.nlm.nih.gov/pubmed/34422708
http://dx.doi.org/10.1155/2021/1412663

Ejemplares similares